A Quality-of-Life-Oriented Endpoint for Comparing Therapies

DOI10.2307/2531683zbMath0715.62262OpenAlexW2040308389WikidataQ52521595 ScholiaQ52521595MaRDI QIDQ3201574

Richard D. Gelber, Rebecca S. Gelman, Aron Goldhirsch

Publication date: 1989

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2531683

zbMATH Keywords

product-limit estimatorKaplan-Meier estimatorquality of lifecancer therapycomparison of therapiesinduced dependencyquantile distance functions

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (30)

Quality-Adjusted Survival Estimation with Periodic Observations: A Multistate Survival Analysis Approach ⋮ Analysis of quality-of-life adjusted failure time data in the presence of competing, possibly informative, censoring mechanisms ⋮ A semi-Markov multistate model for estimation of the mean quality-adjusted survival for non-progressive processes ⋮ Joint Inference for Competing Risks Data Using Multiple Endpoints ⋮ Semiparametric Bayesian Markov analysis of personalized benefit-risk assessment ⋮ Estimating the mean of a mark variable under right censoring on the basis of a state function ⋮ Bayesian regression models for the quality adjusted lifetime data with zero time duration health states ⋮ Nonparametric Estimation of the Bivariate Recurrence Time Distribution ⋮ Testing transition probability matrix of a multi-state model with censored data ⋮ Some geometric methods for constructing decision criteria based on two-dimensional parame\-ters ⋮ A comparison of some confidence intervals for the mean quality-adjusted lifetime with censored data ⋮ Nonparametric Two‐Sample Tests of the Marginal Mark Distribution with Censored Marks ⋮ Simultaneous analysis of quality of life and survival data ⋮ Locally Efficient Estimation of the Quality‐Adjusted Lifetime Distribution with Right‐Censored Data and Covariates ⋮ Efficient Estimation of the Distribution of Quality‐Adjusted Survival Time ⋮ The Two‐Sample Problem with Induced Dependent Censorship ⋮ Survival Analysis in Clinical Trials: Past Developments and Future Directions ⋮ Parametric Estimation of Quality Adjusted Lifetime (QAL) Distribution in Simple Illness-Death Model ⋮ Nonparametric estimator for the survival function of quality adjusted lifetime (QAL) in a three-state illness-death model ⋮ Bayesian analysis of quality adjusted lifetime (QAL) data ⋮ On induced dependent censoring for quality adjusted lifetime (QAL) data in a simple illness-death model ⋮ A note on non-identifiability of mark survival function ⋮ Regression Models for the Mean of the Quality‐of‐Life‐Adjusted Restricted Survival Time Using Pseudo‐Observations ⋮ Joint Regression Analysis of Survival and Quality-Adjusted Survival ⋮ Testing Equality of Survival Functions of Quality-Adjusted Lifetime ⋮ Quality-Adjusted Survival Estimation with Periodic Observations ⋮ Estimation of the mean quality-adjusted survival using a multistate model for the sojourn times ⋮ Revisit Kaplan-Meier estimator in estimating QAL survival distributions ⋮ Empirical likelihood inference for the regression model of mean quality‐adjusted lifetime with censored data ⋮ Nonparametric estimation of quality adjusted lifetime distribution in a simple illness-death model

This page was built for publication: A Quality-of-Life-Oriented Endpoint for Comparing Therapies